SIGYN THERAPEUTICS, INC. (SIGY) Operating cash flow 2015–2024
SIGYN THERAPEUTICS, INC. (SIGY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$872,436FY2024 · since FY2015: -$83,820 → -$872,436
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$872,436 | +36.9% |
| FY2023 | -$1.4M | +24.4% |
| FY2022 | -$1.8M | -3.2% |
| FY2021 | -$1.8M | -113.8% |
| FY2020 | -$829,809 | -477.5% |
| FY2019 | -$143,684 | +49.8% |
| FY2018 | -$286,112 | +28.5% |
| FY2017 | -$400,003 | — |
| FY2015 | -$83,820 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SIGY financial trends
SIGY RevenueSIGY Net incomeSIGY Net marginSIGY Gross profitSIGY Gross marginSIGY Operating incomeSIGY Operating marginSIGY Free cash flowSIGY Capital expendituresSIGY Return on equitySIGY Stock buybacksSIGY Dividends paidSIGY Total assetsSIGY Total liabilitiesSIGY Shareholders’ equitySIGY overview →